AbbVie Research and Development Expenses 2010-2025 | ABBV

AbbVie research and development expenses for the twelve months ending March 31, 2025 were $12.919B, a 76.44% increase year-over-year.

  • AbbVie annual research and development expenses for 2024 were $12.791B, a 66.66% increase from 2023.
  • AbbVie annual research and development expenses for 2023 were $7.675B, a 17.9% increase from 2022.
  • AbbVie annual research and development expenses for 2022 were $6.51B, a 5.95% decline from 2021.

AbbVie Research and Development Expenses 2010-2025 | ABBV

  • AbbVie annual research and development expenses for 2024 were $12.791B, a 66.66% increase from 2023.
  • AbbVie annual research and development expenses for 2023 were $7.675B, a 17.9% increase from 2022.
  • AbbVie annual research and development expenses for 2022 were $6.51B, a 5.95% decline from 2021.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$796.4B
Johnson & Johnson (JNJ)$379.5B
Novo Nordisk (NVO)$260.6B
Roche Holding AG (RHHBY)$248.1B
Novartis AG (NVS)$234.2B
Merck (MRK)$196.7B
Sanofi (SNY)$128.6B
Pfizer (PFE)$125.6B
Bayer (BAYRY)$23.7B
Innoviva (INVA)$1.1B